aap gains CE approval for knee endoprosthetics sector

Metal and biological implant specialist aap Implantate AG has received European certification for an innovative knee endoprosthesis and, accordingly, for the knee endoprosthetics sector. The new knee endoprosthesis was taken to market maturity by aap as part of a development contract for Munich-based HJS Gelenk-System GmbH. In securing CE approval, aap has successfully completed a substantial part of the development contract.

The HJS implant makes almost natural movements possible by means of a surface geometry that has been patented worldwide. The interdisciplinary development team expects implant patients to be able to move their knees after a relatively short time without pain once more and without major restrictions.

Data Monitor estimates the current total European market volume for knee endoprostheses to amount to roughly US $ 450 million. In combining the competence areas of shoulder, hip and knee endoprosthetics along with its already established cement and cement technology products, aap has succeeded in taking a decisive step toward becoming a single-point provider.